Placebo matching BI 1015550, BI 1015550, BI 1015550
1305-0069
Phase 3 small_molecule active
Quick answer
Placebo matching BI 1015550, BI 1015550, BI 1015550 for Interstitial lung diseases, Familial pulmonary fibrosis, Pulmonary fibrosis is a Phase 3 program (small_molecule) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Interstitial lung diseases, Familial pulmonary fibrosis, Pulmonary fibrosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active